| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |